Bausch+Lomb IPO Presentation Deck

Key consumer eye care products address customer needs Suite of Market-Leading, High-Growth Products PreserVisionⓇ BAUSCH+ LOMB PreserVision. NUTRITIONALS AREDS 2 TUBULA #1 in US1 OcuviteⓇ BAUSCH+ LOMB BAUSCH+COME Ocuvite ADULT 50+ #1 doctor recommended in U.S.6 J Ocuvite #1 in US1 LENS CARE Biotrue®, Renu® AR Bio Bio true frue #1 in China², Japan³ & Canada4 60% unit share in multipurpose solutions in U.S.7 Boston Gostar 1. Bausch + Lomb Consumer Data Science, IRI Data, Mulo US. Latest Data Ending 11-14-21 2. FY2019. Third party data. 3. YTD Oct 2021. Intage SRI+ for OTC market (off-take). 4. MAT Oct 2021. Nielsen, National GB+DR+MM 5. YTD June 2021, IQVIA Pharma 6. Bausch+Lomb Consumer Data Science, IQVIA ProVoice Total US, Data Ending Q3 2021 7. Source: B+L Consumer Data Science, IRI, Total US Omnichannel, Panel, Unit Sales, L52WE 10-31-2021. Futu ReNu LumifyⓇ 12 LUMIFY #1 in US¹1 LIFORY 45 SENTIM #1 doctor recommended in U.S.6 EN-E Camerejela Ja EYE DROPS Mioclear ™M WIE |萘敏维滴眼液 | GENSEREMEES BAUSCH LOND #1 in China5 TAMEN HOEK Bio true Spor CONSUMER HEALTH CARE 14 MIM 复方硫酸软骨素造| BAUSCH&LOME Artelac® Artelac Rebalance naHSONE Ariolet Kw SAUL Alaway 24

View entire presentation